v3.26.3
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenues $ 72 $ 418
Cost of Revenues (1,095) (2,083)
Gross loss (1,023) (1,665)
Research and development, net (1,629) (1,171) (4,781) (4,741)
Sales and marketing (2,001) (531) (5,257) (531)
General and administrative (1,841) (2,159) (5,298) (5,333)
Operating loss (6,494) (3,861) (17,001) (10,605)
Other income (see Note 3F) 316
Financing income, net 652 284 1,861 611
Net loss $ (5,842) $ (3,577) $ (15,140) $ (9,678)
Basic net loss per share $ (0.09) $ (0.07) $ (0.23) $ (0.25)
Diluted net loss per share $ (0.09) $ (0.07) $ (0.23) $ (0.25)
Basic weighted average common shares outstanding 67,164,801 48,095,384   38,618,642
Diluted weighted average common shares outstanding 67,164,801 48,095,384 67,162,177 38,618,642